Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langdon

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Scientific Reports|June 9, 2015
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model systemAntonis Koussounadis, Simon P Langdon, In Hwa Um, et al.
Molecular Cancer Research : MCR|September 10, 2009
Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivityYoko Nagumo, Dana Faratian, Peter Mullen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2010
Cancer systems biologyDana Faratian, James L Bown, V Anne Smith, et al.
British Journal of Cancer|March 5, 2002
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2010
Reply to: discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?D Faratian, S J Aitken, J S Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancerPeter Mullen, Fiona McPhillips, Kenneth MacLeod, et al.
Journal of Biotechnology|December 3, 2014
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cellsHilal S Khalil, Alexey Goltsov, Simon P Langdon, et al.
British Journal of Cancer|May 5, 2005
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomasO Gubbay, W Guo, M T Rae, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyDana Faratian, Inhwa Um, Danielle S Wilson, et al.
Metabolites|February 15, 2018
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation ResponsivenessCarol Ward, James Meehan, Mark Gray, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Scientific Reports|June 9, 2015
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model systemAntonis Koussounadis, Simon P Langdon, In Hwa Um, et al.
Molecular Cancer Research : MCR|September 10, 2009
Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivityYoko Nagumo, Dana Faratian, Peter Mullen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2010
Cancer systems biologyDana Faratian, James L Bown, V Anne Smith, et al.
British Journal of Cancer|March 5, 2002
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2010
Reply to: discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?D Faratian, S J Aitken, J S Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancerPeter Mullen, Fiona McPhillips, Kenneth MacLeod, et al.
Journal of Biotechnology|December 3, 2014
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cellsHilal S Khalil, Alexey Goltsov, Simon P Langdon, et al.
British Journal of Cancer|May 5, 2005
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomasO Gubbay, W Guo, M T Rae, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyDana Faratian, Inhwa Um, Danielle S Wilson, et al.
Metabolites|February 15, 2018
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation ResponsivenessCarol Ward, James Meehan, Mark Gray, et al.
Pageof 18